| 000 | 02552nam a2200505 i 4500 | ||
|---|---|---|---|
| 999 |
_c281069 _d281069 |
||
| 001 | on1097680969 | ||
| 003 | OCoLC | ||
| 005 | 20190515141316.0 | ||
| 007 | he bmb024bbca | ||
| 008 | 190419s2018 dcu bb f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a1019-B-01 (MF) | ||
| 086 | 0 | _aY 4.C 73/8:115-109 | |
| 088 | _aSerial no. 115-109 (United States. Congress. House. Committee on Energy and Commerce) | ||
| 099 | _aY 4.C 73/8:115-109 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Health, |
|
| 240 | 1 | 0 | _aReauthorization of animal drug user fees (2018) |
| 245 | 1 | 0 |
_aReauthorization of animal drug user fees : _bADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 14, 2018. |
| 246 | 3 | 0 | _aADUFA and AGDUFA |
| 264 | 1 |
_aWashington : _bU.S. Government Publishing Office, _c2018. |
|
| 300 |
_aiii, 132 pages ; _c24 cm |
||
| 336 | _btxt | ||
| 337 |
_bh _2rdamedia |
||
| 338 |
_bhe _2rdacarrier |
||
| 500 | _a"Serial no. 115-109." | ||
| 500 | _aShipping list no.: 2019-0045-M. | ||
| 500 | _aCRDP Program record. | ||
| 504 | _aIncludes bibliographical references. | ||
| 533 |
_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2018] _e2 microfiches : negative. |
||
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. _sReauthorization of animal drug user fees (2018) _w(DLC) 2017393544 _w(OCoLC)1057445887 |
| 776 | 0 | 8 |
_iOnline version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. _sReauthorization of animal drug user fees (2018) _w(OCoLC)1062352811 |
| 050 | 4 |
_aKF27 _b.E553 2018 |
|
| 610 | 1 | 0 |
_aUnited States. _tAnimal Drug User Fee Act of 2003. |
| 610 | 1 | 0 |
_aUnited States. _tAnimal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013. |
| 610 | 2 | 0 |
_aCenter for Veterinary Medicine (U.S.) _xFinance. |
| 610 | 2 | 0 |
_aCenter for Veterinary Medicine (U.S.) _xCustomer services. |
| 650 | 0 |
_aVeterinary drugs _xTesting _xGovernment policy _zUnited States. |
|
| 650 | 0 |
_aDrug approval _zUnited States _xCosts. |
|
| 650 | 0 |
_aFood of animal origin _xGovernment policy _zUnited States. |
|
| 650 | 0 |
_aFees, Administrative _zUnited States. |
|
| 655 | 7 |
_aLegislative hearings. _2lcgft |
|
| 942 |
_2sudocs _c8 |
||